The Jagsonpal Pharmaceuticals Buyback 2026 last day to buy is not available as of now.

The Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer.

Sorry, the Jagsonpal Pharmaceuticals Buyback 2026 timelines are not available at this time.

The Jagsonpal Pharmaceuticals Buyback 2026 is being offered at Rs ₹250 per share.

The Jagsonpal Pharmaceuticals Buyback 2026 record date is not yet declared.

The issue size of Jagsonpal Pharmaceuticals Buyback 2026 is 16,00,000 equity shares at ₹250 per share aggregating up to ₹40.00 Crores.

The necessity for Jagsonpal Pharmaceuticals Buyback 2026 is not yet declared.

Letter of Offer

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Jagsonpal Pharmaceuticals Buyback 2026 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one’s need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.